Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORγt

European Journal of Immunology

Volumn 38, Issue 5, 2008, Pages 1204-1214

  Yang, Jianfei ^a   Yang, Min ^b   Htut, Tin Min ^a   Ouyang, Xinshou ^b   Hanidu, Adedayo ^a   Li, Xiang ^a   Sellati, Rosemarie ^a   Jiang, Huiping ^a   Zhang, Shu ^b   Li, Hongxing ^b   Zhao, Jie ^b   Ting, Adrian T ^b   Mayer, Lloyd ^b   Unkeless, Jay C ^b   Labadia, Mark E ^a   Hodge, Martin ^a   Li, Jun ^a   Xiong, Huabao ^b  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Gene regulation; T helper cells

Indexed keywords

INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 27; OVALBUMIN; PROTEIN P28; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RORGAMMAT; UNCLASSIFIED DRUG; VIRUS PROTEIN; EBI3 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GAMMA INTERFERON; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; LYMPHOCYTE ANTIGEN RECEPTOR; ORPHAN NUCLEAR RECEPTOR ROR GAMMA; ORPHAN NUCLEAR RECEPTOR ROR-GAMMA; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL IMMUNITY; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; HELPER CELL; IMMUNIZATION; IN VITRO STUDY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROVOCATION TEST; SPLEEN CELL; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CD4+ T LYMPHOCYTE; CYTOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LISTERIOSIS; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-17; INTERLEUKINS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47049114262     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200838145     Document Type: Article

References (35)

1. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. and Murphy, K. M., Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006. 24: 677-688.
2. Liang, S. C., Tan, X. Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M. and Fouser, L. A., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006. 203: 2271-2279.
3. Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J. and Ouyang, W., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007. 445: 648-651.
4. Kolls, J. K. and Linden, A., Interleukin-17 family members and inflammation. Immunity 2004. 21: 467-476.
5. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R.,Wang, Y. H.,Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 1133-1141.
6. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
7. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
8. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179-189.
9. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231-234.
10. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
11. + T helper cells. Cell 2006. 126: 1121-1133.
12. Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L. et al., IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002. 16: 779-790.
13. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H. et al., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004. 172: 2225-2231.
14. Devergne, O., Birkenbach, M. and Kieff, E., Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. USA 1997. 94: 12041-12046.
15. Niedbala, W., Wei, X. Q., Cai, B., Hueber, A. J., Leung, B. P., McInnes, I. B. and Liew, F. Y., IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 2007. 37: 3021-3029.
16. Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R. et al., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007. 450: 566-569.
17. Nieuwenhuis, E. E., Neurath, M. F., Corazza, N., Iijima, H., Trgovcich, J., Wirtz, S., Glickman, J. et al., Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. USA 2002. 99: 16951-16956.
18. Zahn, S., Wirtz, S., Birkenbach, M., Blumberg, R. S., Neurath, M. F. and von Stebut, E., Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major. Eur. J. Immunol. 2005. 35: 1106-1112.
19. Wirtz, S., Tubbe, I., Galle, P. R., Schild, H. J., Birkenbach, M., Blumberg, R. S. and Neurath, M. F., Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 2006. 203: 1875-1881.
20. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M. et al., WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001. 15: 569-578.
21. + T cells through Stat1-dependent and - independent mechanisms. Proc. Natl. Acad. Sci. USA 2003. 100: 15047-15052.
22. Batten, M., Li, J., Yi, S., Kljavin, N.M., Danilenko, D. M., Lucas, S., Lee, J. et al., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 2006. 7: 929-936.
23. Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V. et al., Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006. 7: 937-945.
24. Miyamoto, M., Emoto, M., Emoto, Y., Brinkmann, V., Yoshizawa, I., Seiler, P., Aichele, P. et al., Neutrophilia in LFA-1-deficient mice confers resistance to listeriosis: Possible contribution of granulocyte-colony-stimulating factor and IL-17. J. Immunol. 2003. 170: 5228-5234.
25. + lymphocytes responding to infection with Listeria monocytogenes. J. Immunol. 2005. 175: 394-403.
26. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
27. Rosas, L. E., Satoskar, A. A., Roth, K. M., Keiser, T. L., Barbi, J., Hunter, C., de Sauvage, F. J. and Satoskar, A. R., Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology. Am. J. Pathol. 2006. 168: 158-169.
28. Kelly, M. N., Kolls, J. K., Happel, K., Schwartzman, J. D., Schwarzenberger, P., Combe, C., Moretto, M. and Khan, I. A., Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 2005. 73: 617-621.
29. Goldberg, R., Zohar, Y., Wildbaum, G., Geron, Y., Maor, G. and Karin, N., Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27. J. Immunol. 2004. 173: 6465-6471.
30. Goldberg, R., Wildbaum, G., Zohar, Y., Maor, G. and Karin, N., Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J. Immunol. 2004. 173: 1171-1178.
31. Zambrowicz, B. P., Friedrich, G. A., Buxton, E. C., Lilleberg, S. L., Person, C. and Sands, A. T., Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 1998. 392: 608-611.
32. lo thymocytes in vivo. Science 1990. 250: 1720-1723.
33. + Th1 cells. J. Immunol. 2005. 175: 6580-6588.
34. Li, X. and Wang, X., Application of real-time polymerase chain reaction for the quantitation of interleukin-1beta mRNA upregulation in brain ischemic tolerance. Brain Res. Brain Res. Protoc. 2000. 5: 211-217.
35. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.